Skip to main content
. 2022 Apr 18;40(1):37–48. doi: 10.12701/jyms.2022.00031

Fig. 1.

Fig. 1.

Proportion of patients who maintained use of probiotics among those prescribed probiotics stratified by the type of inflammatory bowel disease. CD, Crohn disease; UC, ulcerative colitis.